|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Nov 12, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current assets | |||||||||||||||||
| Cash | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Short-term investments | |||||||||||||||||
| Accounts receivable | |||||||||||||||||
| Unbilled receivable | |||||||||||||||||
| Related party receivable | |||||||||||||||||
| Inventory | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Property, plant, and equipment, net | |||||||||||||||||
| Right-of-use assets | |||||||||||||||||
| Equity method investments | |||||||||||||||||
| Investments in equity securities | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Other accrued expenses | |||||||||||||||||
| Horizon IP agreement payable | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued liabilities | |||||||||||||||||
| Related party payables | |||||||||||||||||
| Contract liabilities | |||||||||||||||||
| Current portion of lease liabilities | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long term liabilities | |||||||||||||||||
| Lease liabilities | |||||||||||||||||
| Private placement warrant liability | |||||||||||||||||
| Earnout liability | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| July 2024 warrant liability | |||||||||||||||||
| Accrued SEC settlement | |||||||||||||||||
| Other liabilities | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Stockholders’ Equity | |||||||||||||||||
| Common stock, $0.0001 par value; 20,000,000 shares authorized, 5,510,056 and 4,901,630 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. | |||||||||||||||||
| Total common stock, $0.0001 par value; 20,000,000 shares authorized, 5,510,056 and 4,901,630 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. | |||||||||||||||||
| Treasury stock, at cost; 75,392 shares as of September 30, 2024 and December 31, 2023, respectively. | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Hyzon Motors Inc. stockholders’ equity | |||||||||||||||||
| Total Hyzon Motors Inc. stockholders’ equity | |||||||||||||||||
| Noncontrolling interest | |||||||||||||||||
| Total Stockholders’ Equity | |||||||||||||||||
| Total Liabilities and Stockholders’ Equity | |||||||||||||||||
Loading...